Paul King, President of MyMatrixx by Evernorth, outlines how to integrate advanced tech and clinical precision to elevate PBMs in a complex regulatory landscape.
BHSI’s Ben Wyatt leads a marine insurance underwriting team that values collaboration and gains knowledge through a respectful challenging of individual assumptions.
The miscellaneous professional liability market is comprised of hundreds of different professions. Westfield Specialty makes a point of being an insurance solution for the professions with unique and specialized risk.
This expert-backed Q&A will help you ask the right questions to assess whether your physical therapy network is proactively driving better outcomes or simply reacting to treatment requests.
As catastrophic losses mount and traditional risk transfer approaches reach their limits, insurers are turning to building science and engineering solutions to bend the cost curve downward.
Discover how to reduce chaos in auto casualty claims with three proven solutions that address social inflation and claim severity, improving accuracy, efficiency, and adjuster negotiations.
As IRS scrutiny intensifies and new reporting requirements emerge, orgs utilizing micro-captive insurance companies face critical decisions about risk management approaches.
Each year Enlyte releases its drug trends series to analyze the state of pharmacy trends in workers’ comp. In part one of our 2025 series, we’re evaluating retail and mail order prescriptions.
With inflation, supply-chain issues, and tech shifts, equipment breakdown reinsurance is regaining focus. Matt Stambaugh of Travelers BoilerRe shares how these forces are driving carriers to rethink strategies.
Registration is open for the 2025 TxCIA Annual Conference, October 14–15 in The Woodlands, TX—featuring expert panels, networking, and the latest insights in captive insurance.
With rising complexity and evolving technologies, equipment breakdown risks are growing — Travelers VP, Pete Schulz, delivers expert insight to help businesses stay ahead.
Migraine medications are making up a growing portion of pharmacy spend in workers’ comp, driven by an influx of new CGRP antagonist medications to the market over the last few years.